[Comment] An effective and safe vaccine will not be enough to prepare us for the next Ebola outbreak

In The Lancet Infectious Disease, Pierre-St éphane Gsell and colleagues1 present safety and efficacy data on the deployment of the rVSV-ZEBOV vaccine during an outbreak of Ebola virus disease in Guinea, 2016. On March 17, 2016, almost 3 months after Guinea was first declared Ebola virus disease-free, two new cases of Ebola virus disease were confirmed.2 Fortunately, members of the Ebola Ça Suffit! team were meeting in the capital, Conakry. Less than 1 week after the first cases were confirmed, the previously trained team members travelled to the epicentre of the flare and began the process of identifying contacts and contacts of conta cts for vaccination.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Comment Source Type: research